Clinical trial shows effectiveness of AI-driven app
Sweetch is a start-up with a mobile health app that aims to use AI to help users prevent diabetes — or improve outcomes for users who have diabetes. The app personalizes recommendations for each user, offering them the tailored support and encouragement they need to make long-term behavior changes. In 2016, Sweetch raised $3.5 million, led by global conglomerate Philips and equity crowdfunding platform OurCrowd.
A clinical trial conducted at Johns Hopkins University found that Sweetch was highly effective at modifying participant behavior. On average, participants lost weight, reduced their waist circumference and had a clinically meaningful reduction in their A1C levels.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.